Loading data
NVCTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 18.15 m USD | 12.92 m USD | 15.38 m USD | 13.23 m USD | 9.55 m USD |
| Operating profit | -27.57 m USD | -19.85 m USD | -22.9 m USD | -19.23 m USD | -12.89 m USD |
| Net income (reported basis) | -26.44 m USD | -19 m USD | -22.26 m USD | -19.09 m USD | -12.89 m USD |
| Net income attributable to common shareholders | -28.87 m USD | -19 m USD | -22.26 m USD | -19.09 m USD | -12.89 m USD |
| Basic earnings per share | -1.32 USD/share | -1.11 USD/share | -1.43 USD/share | -1.51 USD/share | -3.02 USD/share |
| Diluted earnings per share | -1.32 USD/share | -1.11 USD/share | -1.43 USD/share | -1.51 USD/share | -3.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.